scholarly journals Experiences of patients with lung cancer receiving concurrent chemo-radiotherapy

2021 ◽  
Vol 5 (1) ◽  
pp. 015-023
Author(s):  
Choi Eunsook ◽  
Park Sunhee
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Radiation Treatment ◽  
Structured Interviews ◽  
Improvement Program ◽  
Lung Cancer Patients ◽  
Core Category ◽  
Depth Interview ◽  
Life Improvement ◽  
Medical Teams

Purpose: In an aspect of qualitative treatment, this research gathered lung cancer patients’ actual experiences to understand deeply, such as their expectation for treatment results, their difficulties during treatment, and their various requests to their family and medical teams. Methods: From May to June 2013, semi-structured interviews were conducted with 9 lung cancer patients. Data were collected through a tape-recorded in-depth interview. The analysis of the data was made through the qualitative method. Results: 124 themes regarding the experience were found. From these 35 concepts, 24 subcategories were emerged. The core category was enduring hardship of the treatment with the hope for full recovery. Six categories included ‘Wishing to be cured but concern about recurrence’, ‘Receiving radiation treatment with pleasure and difficult at the same time’. ‘Being sorry for their family’s full support and trying to stand alone‘, ‘Having confidence in their medical team’, ‘regretting for their old days’, and ‘Wanting to live a long life without illness and pain’. Conclusion: The results of this study would help oncology nurses to understand the lung cancer patients receiving concurrent chemo-radiotherapy (CCRT) and to develop a quality of life improvement program for physical, psychosocial, and spiritual aspects of nursing.

Systematic intrafraction shifts of mediastinal lymph node targets between setup imaging and radiation treatment delivery in lung cancer patients

2018 ◽  
Vol 126 (2) ◽  
pp. 318-324 ◽  
Author(s):  
Mai Lykkegaard Schmidt ◽  
Lone Hoffmann ◽  
Ditte S. Møller ◽  
Marianne Marquard Knap ◽  
Torben Riis Rasmussen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Cancer Patients ◽  
Radiation Treatment ◽  
Mediastinal Lymph Node ◽  
Treatment Delivery ◽  
Lung Cancer Patients

scholarly journals The Proportion of Radiation Pneumonitis among Lung Cancer Patients in Persahabatan Hospital

2020 ◽  
Vol 14 (2) ◽  
pp. 46
Author(s):  
Dini Rizkie Wijayanti ◽  
Jamal Zaini ◽  
Achmad Hudoyo ◽  
Aziza Ghanie ◽  
Westi ATW
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Radiation Pneumonitis ◽  
Background Radiation ◽  
Radiation Treatment ◽  
Smoking History ◽  
Ground Glass ◽  
Radiation Doses ◽  
Lung Cancer Patients ◽  
History Of

Background : Radiation-induced pulmonary toxicity occurs in patients with lung cancer who received irradiation. The objective of this study was to determine the proportion of radiation pneumonitis among lung cancer patients that were exposed to radiation treatment in Persahabatan Hospital. There is no data about proportion of radiation pneumonitis in Indonesia.Methods: This was a retrospective study conducted in Persahabatan Hospital during June 2013– July 2015 using the medical record of lung-cancer patients who received irradiation.Results: 33 lung-cancer patients fulfilled the inclusion criteria. Most of them were male (66.7%), in age ≥ 51 years (63.6%), had a smoking history (75.8%) with moderate Brinkman Index (60%), were given irradiation doses of 3,000–4,000 (60.6%) with irradiation fractions of 10–19 (60.6%), had no history of chemotherapy (54.5%), and were diagnosed with adenocarcinoma (66.7%) and stage-IV cancer (84.84%). The proportion of radiation pneumonitis based on chest X-ray (CXR) was 39.4%; which consisted of hazy ground-glass opacities, hazy ground-glass opacities, and fibrosis, and only fibrosis. There were significant differences in age, radiation doses, and history of chemotherapy with the proportion of radiation pneumonitis (p < .05).Conclusion: The proportion of radiation pneumonitis based on CXR was 39.4%. There were significant differences in age, radiation doses, and history of chemotherapy with the proportion of radiation pneumonitis. 

scholarly journals The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review

2021 ◽  
Vol 28 (6) ◽  
pp. 4247-4255
Author(s):  
Goulnar Kasymjanova ◽  
Aksa Anwar ◽  
Victor Cohen ◽  
Khalil Sultanem ◽  
Carmela Pepe ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Radiation Treatment ◽  
Lung Cancer Surgery ◽  
Retrospective Chart Review ◽  
Diagnosis And Treatment ◽  
Definitive Treatment ◽  
Cancer Center ◽  
Lung Cancer Patients ◽  
The Impact

The large burden of COVID-19 on health care systems worldwide has raised concerns among medical oncologists about the impact of COVID-19 on the diagnosis and treatment of lung cancer patients. In this retrospective cohort study, we investigated the impact of COVID-19 on lung cancer diagnosis and treatment before and during the COVID-19 era. New lung cancer diagnoses decreased by 34.7% during the pandemic with slightly more advanced stages of disease, there was a significant increase in the utilization of radiosurgery as the first definitive treatment, and a decrease in both systemic treatment as well as surgery compared to the pre-COVID-19 era. There was no significant delay in starting chemotherapy and radiation treatment during the pandemic compared to pre-COVID-19 time. However, we observed a delay to lung cancer surgery during the pandemic time. COVID-19 seems to have had a major impact at our lung cancer center on the diagnoses and treatment patterns of lung cancer patients. Many oncologists fear that they will see an increase in newly diagnosed lung cancer patients in the coming year. This study is still ongoing and further data will be collected and analyzed to better understand the total impact of the COVID-19 pandemic on our lung cancer patient population.

scholarly journals Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Katsuyuki Shirai ◽  
Akiko Nakagawa ◽  
Takanori Abe ◽  
Masahiro Kawahara ◽  
Jun-ichi Saitoh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Esophageal Cancer ◽  
Cancer Patients ◽  
Fdg Pet ◽  
Radiation Treatment ◽  
Biological Information ◽  
Radiotherapy Planning ◽  
Lung Cancer Patients ◽  
Tumor Delineation ◽  
Curative Radiotherapy

Radiotherapy plays an important role in the treatment for thoracic cancers. Accurate diagnosis is essential to correctly perform curative radiotherapy. Tumor delineation is also important to prevent geographic misses in radiotherapy planning. Currently, planning is based on computed tomography (CT) imaging when radiation oncologists manually contour the tumor, and this practice often induces interobserver variability. F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) has been reported to enable accurate staging and detect tumor extension in several thoracic cancers, such as lung cancer and esophageal cancer. FDG-PET imaging has many potential advantages in radiotherapy planning for these cancers, because it can add biological information to conventional anatomical images and decrease the inter-observer variability. FDG-PET improves radiotherapy volume and enables dose escalation without causing severe side effects, especially in lung cancer patients. The main advantage of FDG-PET for esophageal cancer patients is the detection of unrecognized lymph node or distal metastases. However, automatic delineation by FDG-PET is still controversial in these tumors, despite the initial expectations. We will review the role of FDG-PET in radiotherapy for thoracic cancers, including lung cancer and esophageal cancer.

Sign in / Sign up

Export Citation Format

Share Document